Gonal-f pen

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

121 competitors in Infertility

#DrugCompanyPhaseTrials

1

Voltaren

Novartis

Phase 3

12

Victoza

Novo Nordisk

Phase 3

13

Depo-Provera

Eli Lilly

Phase 3

—4

Activella

Eli Lilly

Phase 3

—5

Zoladex

AstraZeneca

Phase 3

—6

Gonal-F

EMD Serono

Phase 3

37

Alli

EEngelhard Arzneimittel GmbH & Co.KG

Phase 3

18

Prograf

VVeloxis Pharmaceuticals

Phase 3

19

Human Chorionic Gonadotropin

Merck & Co.

Phase 3

210

Estradiol Valerate

Bayer

Phase 3

1Show 30 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Infertility1 trial

Randomized Controlled Study of Comparing Follitrope Versus Gonal-f in Chinese Infertility Women.

Completed·HHangzhou YuYuan Bioscience Technology Co., Ltd.·Phase 3·NCT03506243·451 enrolled

Intracytoplasmic Sperm Injection1 trial

An Observational Study of Gonal-F Filled by Mass Pens in Multifollicular Stimulation Prior to In-vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI)

Completed·Merck & Co.··NCT01075854·1,539 enrolled

TIA1 trial

AMH and Dosing Regimens for Initial IVF Stimulation Protocols

Completed·RReproductive Specialists of New York·N/A·NCT03098199·78 enrolled

Effectiveness1 trial

A Study to Evaluate the Ease of Use, Local Tolerance, Safety and Effectiveness of Gonal-f® (Filled-by-mass in a Prefilled Pen)

Completed·Merck & Co.··NCT01115725·76 enrolled

Ovarian Stimulation1 trial

Assessment of the Role of Serum FSH Monitoring During Ovarian Stimulation and Identification of an Optimal Range for Expected Normal Responders

Recruiting·AART Fertility Clinics LLC··NCT06572930·150 enrolled

Details

Drug Info

Related News